The Food and Drug Administration's approval of Ozempic in 2021 for weightloss treatment ushered in a new era for the class of drugs called glucagon-like peptide-1 agonists, or GLP-1. Today ...
A new study conducted by researchers from the University of Eastern Finland the Karolinska Institutet explored the ways that weightlossdrugs like Ozempic and Wegovy can serve another purpose ...